Executive Summary
Bayer Corporation challenged the order by the Intellectual Property Appellate Board (IPAB) which upheld the Controller's decision to grant a Compulsory License to Natco Pharma Limited. The license was granted for Bayer's patented drug, Sorafenib Tosylate (Nexavar), used in treating various cancers.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Bombay High Court. Understanding the court's reasoning in Bayer Corporation vs Union of India Through The Secretary; The Controller of Patents; Natco Pharma Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Biswanath Hosiery Mills LtdvsMicky Metals Ltd And Anr
The Calcutta High Court granted Biswanath Hosiery Mills Ltd liberty to file a supplementary affidavit, allowing them to introduce two key letters from the private respondent into evidence. The court also directed the petitioner to ensure proper representation for the Registrar of Trademark (Respondent No. 2). This interim order keeps the trademark dispute active and sets the matter for further hearing on August 29, 2025.
Amultek Software Solutions Pvt LtdvsKaira District Co-Operative Milk Producers Union Ltd
The Gujarat High Court addressed a challenge to an interim order preventing Amultek Software Solutions from using the name 'Amultek' due to trademark concerns raised by Kaira District Co-Operative Milk Producers Union Ltd. The court allowed the application filed by Amultek, permitting them to temporarily change their name to Atek Software Solutions Pvt Ltd while reserving their right to contest the underlying infringement claims in the main appeal. This decision allows the litigation to proceed toward a final determination of trademark rights.
Novartis AgvsMsn Laboratories Pvt. Ltd
The suit seeks a permanent injunction against the defendant for infringement of Patent No. 210284, along with damages and other reliefs. The patent has expired, and the remaining issue pertains to the payment of damages.
Qrg Enterprises & Anr.vsHpl (India) Limited & Ors.
The Delhi High Court decreed a trademark dispute between Qrg Enterprises and HPL (India) Limited based on a comprehensive settlement agreement. The court upheld the plaintiffs' proprietary rights in the 'HAVELLS/HAVELL'S' mark, granting permanent injunctions against the defendants. Crucially, the judgment clarified that since the defendant's name change was mandated by the decree and not voluntary, they would not be bound by the proviso to Section 12(3) of the Companies Act, 2013, ensuring the settlement's enforceability.
Amylin Pharmaceuticals, Llc And AnrvsAssistant Controller Of Patents And Designs
Amylin Pharmaceuticals appealed the Assistant Controller's rejection of its patent application for 'RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS'. The appeal challenged the finding that the invention lacked inventive step and fell under Section 3(d).
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.